FI971879A0 - Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi - Google Patents

Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi

Info

Publication number
FI971879A0
FI971879A0 FI971879A FI971879A FI971879A0 FI 971879 A0 FI971879 A0 FI 971879A0 FI 971879 A FI971879 A FI 971879A FI 971879 A FI971879 A FI 971879A FI 971879 A0 FI971879 A0 FI 971879A0
Authority
FI
Finland
Prior art keywords
allogeneic
antibodies
diagnosis
determination
treatment
Prior art date
Application number
FI971879A
Other languages
English (en)
Swedish (sv)
Other versions
FI971879A (fi
Inventor
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of FI971879A0 publication Critical patent/FI971879A0/fi
Publication of FI971879A publication Critical patent/FI971879A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI971879A 1994-11-04 1997-05-02 Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi FI971879A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002238A IT1276860B1 (it) 1994-11-04 1994-11-04 Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
PCT/EP1995/004239 WO1996014340A1 (en) 1994-11-04 1995-10-30 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof

Publications (2)

Publication Number Publication Date
FI971879A0 true FI971879A0 (fi) 1997-05-02
FI971879A FI971879A (fi) 1997-06-24

Family

ID=11369803

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971879A FI971879A (fi) 1994-11-04 1997-05-02 Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi

Country Status (26)

Country Link
EP (1) EP0789716B1 (fi)
JP (1) JPH10508591A (fi)
KR (1) KR100426029B1 (fi)
CN (1) CN1046737C (fi)
AR (1) AR002243A1 (fi)
AT (1) ATE192166T1 (fi)
AU (1) AU690756B2 (fi)
BR (1) BR9509556A (fi)
CA (1) CA2204380A1 (fi)
CZ (1) CZ288322B6 (fi)
DE (1) DE69516534T2 (fi)
DK (1) DK0789716T3 (fi)
ES (1) ES2147617T3 (fi)
FI (1) FI971879A (fi)
GR (1) GR3033956T3 (fi)
HU (1) HUT76880A (fi)
IL (1) IL115862A (fi)
IT (1) IT1276860B1 (fi)
NO (1) NO972046L (fi)
NZ (1) NZ295171A (fi)
PL (1) PL181115B1 (fi)
PT (1) PT789716E (fi)
RU (1) RU2160445C2 (fi)
TR (1) TR199501353A2 (fi)
WO (1) WO1996014340A1 (fi)
ZA (1) ZA959255B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283634B1 (it) * 1996-05-10 1998-04-23 Zetesis Spa Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali
US20010014471A1 (en) * 1999-04-15 2001-08-16 Vytautas Naktinis Recombinant protein and its use in therapy and diagnostics
IT201600127428A1 (it) * 2016-12-16 2018-06-16 Cusani Alberto Bartorelli Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne
IT201900022203A1 (it) * 2019-11-26 2021-05-26 Cusani Alberto Bartorelli Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.

Also Published As

Publication number Publication date
ES2147617T3 (es) 2000-09-16
KR100426029B1 (ko) 2004-07-31
IL115862A0 (en) 1996-01-31
FI971879A (fi) 1997-06-24
JPH10508591A (ja) 1998-08-25
ZA959255B (en) 1996-05-29
NO972046D0 (no) 1997-05-02
KR970707161A (ko) 1997-12-01
DK0789716T3 (da) 2000-10-09
PT789716E (pt) 2000-09-29
MX9703191A (es) 1997-07-31
ATE192166T1 (de) 2000-05-15
NO972046L (no) 1997-05-02
CN1046737C (zh) 1999-11-24
BR9509556A (pt) 1997-09-16
AR002243A1 (es) 1998-03-11
CZ131497A3 (en) 1997-12-17
AU690756B2 (en) 1998-04-30
TR199501353A2 (tr) 1996-06-21
AU3845395A (en) 1996-05-31
PL181115B1 (pl) 2001-05-31
HUT76880A (en) 1997-12-29
DE69516534D1 (de) 2000-05-31
PL319878A1 (en) 1997-09-01
CZ288322B6 (en) 2001-05-16
GR3033956T3 (en) 2000-11-30
ITMI942238A1 (it) 1996-05-04
IT1276860B1 (it) 1997-11-03
CN1166838A (zh) 1997-12-03
CA2204380A1 (en) 1996-05-17
WO1996014340A1 (en) 1996-05-17
RU2160445C2 (ru) 2000-12-10
ITMI942238A0 (it) 1994-11-04
NZ295171A (en) 1998-07-28
EP0789716A1 (en) 1997-08-20
EP0789716B1 (en) 2000-04-26
IL115862A (en) 2001-06-14
DE69516534T2 (de) 2000-11-30

Similar Documents

Publication Publication Date Title
ATE163195T1 (de) Lösliche liganden für cd40
IS4416A (is) Líkamsþyngdarstillar (modulators), samsvarandi kjarnsýrur og prótein, og notkun þeirra við sjúkdómsgreiningar og í læknismeðhöndlun
DE69534151D1 (de) Gefriergetrocknete Blutzellen, Stammzellen und Plättchen und Verfahren zu deren Herstellung
EE9600192A (et) Antikehad, mis seostuvad putuka soole valkudele, ja nende kasutamine
DE3750342T2 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
ES521401A0 (es) Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes.
DE3703711A1 (de) Kreuz-schuetzende monoklonale humanantikoerper und diese enthaltende mittel
NO882792D0 (no) Fremstilling og anvendelse av promotere for ekspresjon av fremmed-dna i metylotrofebakterier.
EP0109434A4 (en) IN VITRO DIAGNOSTICS METHODS USING MONOCLONAL ANTIBODIES AGAINST PROTEINS OF CONNECTIVE TISSUES.
FI971879A0 (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
DE69201351D1 (de) Molkeproteingel und Verfahren zu dessen Herstellung.
AU7732887A (en) Antibodies for use in determining human glycoalbumin
DE69110861D1 (de) Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung.
SE9503044D0 (sv) Antibodies for use in cancer therapy and diagnosis
ZA876206B (en) Antibodies for use in determining human glycoalbumin
DE68914886T2 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ITRM960808A0 (it) Immunoconiugati comprendenti anticorpi monoclonali umani o frammenti di essi per diagnosi in vivo e terapia
SI0804236T1 (en) Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
DE69000237T2 (de) Bleichfixier-regenerationssatz und verwendung davon in photographischer behandlung.
IT8911668V0 (it) Scheda semplificata di diagnosi e di trattamento in pratica odontostomatologica
DE3134446A1 (de) Unit system for use in medical analysis and process for preparing same
ZA200301143B (en) Biological materials and methods useful in the diagnosis and treatment of diseases.
RO90502A2 (ro) Metoda de tratament biotrofic in cosmetica geriatrica